RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Rosa A. Maldonado to Chagas Disease

This is a "connection" page, showing publications Rosa A. Maldonado has written about Chagas Disease.
Connection Strength

2.476
  1. Rodriguez F, Luna BS, Calderon O, Manriquez-Roman C, Amezcua-Winter K, Cedillo J, Garcia-Vazquez R, Tejeda IA, Romero A, Waldrup K, Watts DM, Khatchikian C, Maldonado RA. Surveillance of Trypanosoma cruzi infection in Triatomine vectors, feral dogs and cats, and wild animals in and around El Paso county, Texas, and New Mexico. PLoS Negl Trop Dis. 2021 02; 15(2):e0009147.
    View in: PubMed
    Score: 0.708
  2. Buhaya MH, Galvan S, Maldonado RA. Incidence of Trypanosoma cruzi infection in triatomines collected at Indio Mountains Research Station. Acta Trop. 2015 Oct; 150:97-9.
    View in: PubMed
    Score: 0.481
  3. Serna C, Lara JA, Rodrigues SP, Marques AF, Almeida IC, Maldonado RA. A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease. Vaccine. 2014 Jun 12; 32(28):3525-32.
    View in: PubMed
    Score: 0.442
  4. Ramos EI, Garza KM, Krauth-Siegel RL, Bader J, Martinez LE, Maldonado RA. 2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi. J Parasitol. 2009 Apr; 95(2):461-6.
    View in: PubMed
    Score: 0.311
  5. Alonso-Vega C, Urbina JA, Sanz S, Pinazo MJ, Pinto JJ, Gonzalez VR, Rojas G, Ortiz L, Garcia W, Lozano D, Soy D, Maldonado RA, Nagarkatti R, Debrabant A, Schijman A, Thomas MC, L?pez MC, Michael K, Ribeiro I, Gascon J, Torrico F, Almeida IC. New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia. BMJ Open. 2021 12 31; 11(12):e052897.
    View in: PubMed
    Score: 0.188
  6. Ortega-Rodriguez U, Portillo S, Ashmus RA, Duran JA, Schocker NS, Iniguez E, Montoya AL, Zepeda BG, Olivas JJ, Karimi NH, Alonso-Padilla J, Izquierdo L, Pinazo MJ, de Noya BA, Noya O, Maldonado RA, Torrico F, Gascon J, Michael K, Almeida IC. Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of a-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease. Methods Mol Biol. 2019; 1955:287-308.
    View in: PubMed
    Score: 0.153
  7. Maldonado RA, Molina J, Payares G, Urbina JA. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrob Agents Chemother. 1993 Jun; 37(6):1353-9.
    View in: PubMed
    Score: 0.104
  8. Maldonado RA, Kuniyoshi RK, Linss JG, Almeida IC. Trypanosoma cruzi oleate desaturase: molecular characterization and comparative analysis in other trypanosomatids. J Parasitol. 2006 Oct; 92(5):1064-74.
    View in: PubMed
    Score: 0.065
  9. Urbina JA, Lazardi K, Marchan E, Visbal G, Aguirre T, Piras MM, Piras R, Maldonado RA, Payares G, de Souza W. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother. 1993 Mar; 37(3):580-91.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support